BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sylvester PW. Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment. Genes Nutr 2012;7:63-74. [PMID: 21533791 DOI: 10.1007/s12263-011-0225-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Alqahtani S, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A. Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS). Lipids 2014;49:819-29. [PMID: 24934591 DOI: 10.1007/s11745-014-3923-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
2 Tiwari RV, Parajuli P, Sylvester PW. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy. Mol Cell Biochem 2015;408:123-37. [PMID: 26112904 DOI: 10.1007/s11010-015-2488-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
3 Abdul-Majeed S, Mohamed N, Soelaiman IN. Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evid Based Complement Alternat Med 2012;2012:960742. [PMID: 22927884 DOI: 10.1155/2012/960742] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
4 Licarete E, Sesarman A, Banciu M. Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems. J Microencapsul. 2015;32:619-631. [PMID: 26299551 DOI: 10.3109/02652048.2015.1073383] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
5 Gagic Z, Ivkovic B, Srdic-rajic T, Vucicevic J, Nikolic K, Agbaba D. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs. European Journal of Pharmaceutical Sciences 2016;88:59-69. [DOI: 10.1016/j.ejps.2016.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
6 Abdul Rahman A, Jamal AR, Harun R, Mohd Mokhtar N, Wan Ngah WZ. Gamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells. BMC Complement Altern Med 2014;14:213. [PMID: 24980711 DOI: 10.1186/1472-6882-14-213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
7 Gagic Z, Nikolic K, Ivkovic B, Filipic S, Agbaba D. QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells. Journal of the Taiwan Institute of Chemical Engineers 2016;59:33-44. [DOI: 10.1016/j.jtice.2015.07.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
8 Abdul-Majeed S, Mohamed N, Soelaiman IN. The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy. Life Sci 2015;125:42-8. [PMID: 25534439 DOI: 10.1016/j.lfs.2014.12.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
9 Tuerdi G, Ichinomiya S, Sato H, Siddig S, Suwa E, Iwata H, Yano T, Ueno K. Synergistic effect of combined treatment with gamma-tocotrienol and statin on human malignant mesothelioma cells. Cancer Lett 2013;339:116-27. [PMID: 23879968 DOI: 10.1016/j.canlet.2013.07.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
10 Sailo BL, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara AB. Tocotrienols: The promising analogues of vitamin E for cancer therapeutics. Pharmacological Research 2018;130:259-72. [DOI: 10.1016/j.phrs.2018.02.017] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 19.0] [Reference Citation Analysis]